Sarcoid-like reaction in cases treated by checkpoint inhibitors

被引：0
作者：
Semra Paydas
机构：
[1] Çukurova University Faculty of Medicine Department of Medical Oncology,
来源：
Medical Oncology | 2021年 / 38卷
关键词：
Checkpoint inhibitor; Sarcoid-like reaction; Clinical outcome;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Sarcoidosis is a multisystem granulomatous disorder characterized by helper T cell inflammation. Sarcoid-like reaction (SLR) is a well-defined entity and may be related with several malignant disorders and/or their therapies. SLR has been reported more than 20 years ago and in recent years in cases treated by checkpoint inhibitors (CPIs). Better outcome has been reported in cases developing granulomatous reaction and/or SLRs during CPI treatments. However, these lesions clinically may be thought as disease progression and may cause to stop treatment or alterations. These therapeutic manipulations may be harmful for the patients. Clinicians should be aware of SLRs in cases treated by CPIs and tissues must be sampled and reviewed by an experienced pathologist to avoid misdiagnosis and also unnecessary CPI treatment cessations.
引用
收藏
相关论文
共 365 条
  • [1] Hunt BM(2009)Sarcoidosis as a benign cause of lymphadenopathy in cancer patients Am J Surg 197 629-632
  • [2] Valliers E(2007)Sarcoidosis and malignancy Clin Dermatol 25 326-333
  • [3] Buduhan G(2002)Granulomatous reaction after chemotherapy for Hodgkin’s disease Leuk Res 26 967-970
  • [4] Aye R(2015) Calmette–Guerin therapy-associated granulomatous prostatitis mimicking prostate cancer on MRI: a case report and literature review Mol Clin Oncol 3 249-251
  • [5] Louie B(2019)A rare case of granulomatous pneumonitis due to intravesical BCG for bladder cancer Acta Med Port 32 316-320
  • [6] Cohen PR(2009)Anti-CTLA4 monoclonal antibody induced sarcoidosis in a metastatic melanoma patient Dermatology 218 69-70
  • [7] Kurzrock R(2016)Nivolumab-induced sarcoid-like granulomatous reaction in a patient with advanced melanoma Chest 149 133-136
  • [8] Paydas S(2015)Radiographic profiling of immune-related adverse events in advanced melanoma patients treated with ipilimumab Cancer Immunol Res 3 1185-1192
  • [9] Yavuz S(2011)Sarcoidosis is a Th1/Th17 multisystem disorder Thorax 66 144-150
  • [10] Disel U(2012)Increased IL17A expression in granulomas and in circulating memory T cells in sarcoidosis Rheumatology 51 37-46
12345678910